United States · Funded startup
8 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$191Mraised across 8 rounds since 2009, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
No investor was named in the report.
From a historical funding record
Reported by sec.govSEC filing: $400K sold, first sale Sept 2013
Polaris Partners
Lux Capital
Morningside Group
Auriga Partners
SR One
Gates Foundation
Skyline Ventures
Cycad GroupReported by masshightech.comSEC filing: $15M sold, first sale Sept 2012
Polaris PartnersLux CapitalMorningside GroupAuriga PartnersSR OneSkyline VenturesCycad GroupReported by finsmes.comSEC filing: $35M sold, first sale Dec 2010
Polaris PartnersLux CapitalMorningside GroupAuriga PartnersGates FoundationCycad GroupFrom a historical funding recordSEC filing: $35M sold, first sale Dec 2010
Polaris PartnersLux CapitalAuriga PartnersSR OneSkyline VenturesCycad GroupFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Auriga PartnersPolaris PartnersLux CapitalCycad GroupMorningside GroupSR OneGates FoundationSkyline VenturesMissing a round, or an investor who was in one? Tell us.
Genocea Biosciences's investors include Auriga Partners, Polaris Partners, Lux Capital, Johnson & Johnson Development Corporation (JJDC) and MP Healthcare Venture Management, and 5 more on record.
Genocea Biosciences has raised $191M across 8 rounds since 2009.
Genocea Biosciences's most recent round was an Undisclosed round of $52M in Mar 2015.
Its most recent round, $52M in Mar 2015, is also its largest on record.
Genocea Biosciences's first round on record, in Dec 2009, was backed by Polaris Partners, Lux Capital and Auriga Partners and 5 others.
Genocea Biosciences's latest named round is an Undisclosed round, in Mar 2015.
Genocea Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·